Albumin nanoparticles as carriers for a phosphodiester oligonucleotide

International Journal of Pharmaceutics

Volumn 244, Issue 1-2, 2002, Pages 59-72

  Arnedo, A ^a   Espuelas, S ^a   Irache, J M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adsorption; Albumin; Degradation; Nanoparticles; Oligonucleotide; Stability

Indexed keywords

ALBUMIN; BOVINE SERUM ALBUMIN; NANOPARTICLE; OLIGONUCLEOTIDE; PHOSPHODIESTER OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY ELECTROPHORESIS; COACERVATION; DESORPTION; DRUG ADSORPTION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SCREENING; ELECTRICITY; FLUORESCENCE SPECTROSCOPY; HYBRIDIZATION; INCUBATION TIME; IONIC STRENGTH; PH; PRIORITY JOURNAL; PROTEIN INTERACTION;

ALBUMINS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; OLIGONUCLEOTIDES; PARTICLE SIZE;

EID: 0037026277     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00300-9     Document Type: Article

References (36)

1. Abe T., Mizuta T., Hatta T., Miyano-Kurosaki N., Fujiwara M., Takai K., Shigeta S., Yokota T., Takaku H. Antisense therapy of influenza. Eur. J. Pharm. Sci. 13:2001;61-69.
2. Arnedo A., Campanero M.A., Espuelas S., Renedo M.J., Irache J.M. Determination of oligonucleotide ISIS 2922 in nanoparticulate delivery systems by capillary zone electrophoresis. J. Chromatogr. A. 871:2000;311-320.
3. Arshadi R. Albumin microspheres and microcapsules: methodology of manufacturing techniques. J. Controlled Release. 14:1990;11-131.
4. Balladur V.V., Theretz A., Mandrand B. Determination of the main forces driving DNA oligonucleotide adsorption onto aminated silica wafers. J. Colloid Interface Sci. 194:1997;408-418.
5. Berton M., Allemann E., Stein C.A., Gurny R. Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex. Eur. J. Pharm. Sci. 9:1999;163-170.
6. Chavany C., Le Doan T., Couvreur P., Puisieux F., Hélène C. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Pharm. Res. 9:1992;441-449.
7. de Oliveira M.C., Rosilio V., Lesieur P., Bourgaux C., Couvreur P., Ollivon M., Dubernet C. pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water. Biophys. Chem. 87:2000;127-137.
8. Elaissari A., Cros P., Pichot C., Laurent V., Mandrand B. Adsorption of oligonucleotides onto negatively and positively charged latex particles. Colloids Surf. A. 83:1994;25-31.
9. Elaissari A., Chauvet J.P., Halle M.A., Decavallas O., Pichot C., Cros P. Effect of charge nature on the adsorption of single-stranded DNA fragments onto latex particles. J. Colloid Interface Sci. 202:1998;251-260.
10. Fattal E., Vauthier C., Aynie I., Nakada Y., Lambert G., Malvy C., Couvreur P. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J. Controlled Release. 53:1998;137-143.
11. Fresta M., Chillemi R., Spampinato S., Sciuto S., Puglisi G. Liposomal delivery of a 30-mer antisense oligodeoxynucleotide to inhibit proopiomelanocortin expression. J. Pharm. Sci. 87:1998;616-625.
12. Fritz H., Maier M., Bayer E. Cationic polystyrene nanoparticles: preparation and characterization of a model drug carrier system for antisense oligonucleotides. J. Colloid Interface Sci. 195:1997;272-288.
13. Geselowitz D.A., Neckers L.M. Bovine serum albumin is a major oligonucleotide-binding protein found on the surface of cultured cells. Antisense Res. Dev. 5:1995;213-217.
14. Kaneda Y. Virosomes: evolution of the liposome as a targeted drug delivery system. Adv. Drug Delivery Rev. 43:2000;197-205.
15. Lambert G., Fattal E., Brehier A., Feger J., Couvreur P. Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neoshyntesis in HepG2 cells. Biochimie. 80:1998;969-976.
16. Lambert G., Fattal E., Pinto-Alphandary H., Gulik A., Couvreur P. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm. Res. 17:2000;707-714.
17. Lambert G., Fattal E., Couvreur P. Nanoparticulate systems for the delivery of antisense oligonucleotides. Adv. Drug Delivery Rev. 47:2001;99-112.
18. Lambert G., Fattal E., Pinto-Alphandary H., Gulik A., Couvreur P. Polyisobutylcyanoacrylate nanopcapsules containing an aqueous core for the delivery of oligonucleotides. Int. J. Pharm. 214:2001;13-16.
19. Lebedeva I., Benimetskaya L., Stein C.A., Vilenchik M. Cellular delivery of antisense oligonucleotides. Eur. J. Pharm. Biopharm. 50:2000;101-119.
20. Lemaitre M., Bayard B., Lebleu B. Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc. Natl. Acad. Sci. USA. 84:1987;648-652.
21. Leserman L.D., Barbet J., Kourilsky F., Weinstein J.N. Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature. 288:1980;602-604.
22. Lewis K.J., Irwin W.J., Akhtar S. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro. J. Drug Targeting. 5:1998;291-302.
23. Lin W., Coombes A.G., Davies M.C., Davies S.S., Illum L. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J. Drug Targeting. 1:1993;237-243.
24. Merodio M., Arnedo A., Renedo M.J., Irache J.M. Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. Eur. J. Pharm. Sci. 12:2001;251-259.
25. Morimoto Y., Fujimoto S. Albumin microspheres as drug carriers. Crit. Rev. Ther. Drug Carrier Syst. 2:1985;19-63.
26. Nakada Y., Fattal E., Foulquier M., Couvreur P. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Pharm. Res. 13:1996;38-43.
27. Reddy B.P., Dorle A.K., Krishna D.R. Albumin microspheres: effect of process variables on size distribution and in vitro and vitro release. Drug Dev. Ind. Pharm. 16:1990;1791-1803.
28. Rhodes B.A., Zolle I., Buchanan J.W., Wagner H.N.J. Radioactive albumin microspheres for studies of the pulmonary circulation. Radiology. 92:1969;1453-1460.
29. Sato Y., Kaneko K., Mikami K., Mizugaki M., Suzuki Y. Isolation of bovine serum albumin fragment P-9 and P-9 mediated fusion of small unilamellar vesicles. Biol. Pharm. Bull. 22:1999;1360-1365.
30. Simoes S., Slepushkin V., Pires P., Gaspar R., Pedroso de Lima M.C., Düzgünes N. Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim. Biophys. Acta. 1463:2000;459-469.
31. Smith C.C., Aurelian L., Reddy M.P., Miller P.S., Ts'o P.O. Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc. Natl. Acad. Sci. USA. 83:1986;2787-2791.
32. Stephenson M.L., Zamecnik P.C. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. USA. 75:1978;285-288.
33. Teixeira H., Dubernet C., Puisieux F., Benita S., Couvreur P. Submicron cationic emulsions as a new delivery system for oligonucleotides. Pharm. Res. 16:1999;30-36.
34. Wilhelm O., Schmitt M., Hohl S., Senekowitsch R., Graeff H. Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice. Clin. Exp. Metastasis. 13:1995;296-302.
35. Zamecnik P.C., Goodchild J., Taguchi Y., Sarin P.S. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc. Natl. Acad. Sci. USA. 83:1986;4143-4146.
36. Zobel H.P., Junghans M., Maienschein V., Werner D., Gilbert M., Zimmermann H., Noe C., Kreuter J., Zimmer A. Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles. Eur. J. Pharm. Biopharm. 49:2000;203-210.